Shradha Bisht
Nurse Practitioner · Boston, MANPI 1699310458
Payments from drug & device makers
Across 74 payments — averaging $18.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$414
- Amgen$185
- Amarin Pharma, Inc.$180
- Lilly USA, LLC$115
- AstraZeneca$84
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$66
- plus $299 from 9 others
What the payments were for
- Food & beverage$1,343100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $414 |
| Amgen | 10 | $185 |
| Amarin Pharma, Inc. | 10 | $180 |
| Lilly USA, LLC | 7 | $115 |
| AstraZeneca | 5 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $66 |
| GSK | 3 | $55 |
| Biohaven Pharmaceuticals, Inc. | 3 | $53 |
| Novo Nordisk | 2 | $39 |
| Shield Therapeutics Inc | 2 | $37 |
| Agile Therapeutics, Inc. | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 2 | $29 |
| Boehringer Ingelheim | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Bayer | 1 | $16 |
How this compares
$1,343 in reported general payments places this provider in the 90th percentile of 3,855 nurse practitioner providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 35 | $1,308 |
| Atorvastatin Calcium | 88 | $1,234 |
| Lisinopril | 94 | $732 |
| Simvastatin | 45 | $440 |
| Omeprazole | 21 | $387 |
| Amlodipine Besylate | 55 | $376 |
| Levothyroxine Sodium | 30 | $363 |
| Fluticasone Propionate | 16 | $361 |
| Losartan Potassium | 27 | $336 |
| Metoprolol Succinate | 12 | $226 |
| Escitalopram Oxalate | 11 | $205 |
| Gabapentin | 26 | $195 |
| Hydrochlorothiazide | 20 | $161 |
| ValacyclovirValacyclovir Hcl | 13 | $160 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 15 | $126 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Boston
- Alison McManusBoston$346K
- Teresa FogarenBoston$102K
- Carolyn MetivierBoston$93K
- Miu Lai NgBoston$33K
- Lauren BurkeBoston$26K
- Ashley HilmesBoston$24K
- Kristina SkarbinskiBoston$24K
- Hilary UgrasBoston$19K
- Colleen TigheBoston$17K
- Stephanie McDonaldBoston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.